Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study:A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with orwithout Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients withDefici
- Abdelrahim, Maen (PI)
- Bernicker, Eric H. (CoI)
- Darcourt, Jorge (CoI)
- Heyne, Kirk (CoI)
- Singh, Monisha (CoI)
- Lehane, Daniel E. (Key Personnel)
Project: Non Profit